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Background: Our prospective investigation aimed to determine and analyze the incidence and the determinants
of endoleaks after thoracic stent graft.
Methods: Sixty-one patients affected by thoracic aortic aneurysms were treated between January 2000 and
March 2008. The study cohort contained 54 men, with a mean age of 63.6  17.9 years. The follow-up imaging
protocol included chest radiographs and triple-phase computed tomographic angiography performed at 1, 4, and
12 postoperative months and annually thereafter.
Results: Median follow-up was 32.4 months (range: 1–96 months). Endoleaks were detected in 9 (14.7%)
patients, of which 7 were type 1. Five endoleaks were detected at 30 postoperative days, and the other 4 developed
with a mean delay of 12 months. Endovascular or hybrid interventions were used to treat the endoleaks. Second-
ary technical success rate was 100%. Multivariate analysis demonstrated that the diameter of the aneurysmal
aorta (odds ratio 1.75, 95% confidence interval 1.07–2.86) and the coverage of the left subclavian artery
(odds ratio 12.05, 95% confidence interval 1.28–113.30) were independently associated with endoleak develop-
ment. The percentages of patients in whom reinterventions were unnecessary were 94.6%  3.0%, 88.3% 
4.5%, and 85.4% 5.2%, at 1, 2, and 5 years, respectively. The actuarial survival estimates at 1, 2, and 5 years
were 85.2%  4.6%, 78.1%  5.4%, and 70.6%  6.4%, respectively.
Conclusions: The diameter of the aneurysmal aorta and the position of the landing zone are independent predic-
tors of endoleak occurrence after thoracic stent-graft procedures. A careful follow-up program should be
considered in patients in whom these indices are unfavorable, because most of the endoleaks may be successfully
and promptly treated by additional endovascular procedures.Endovascular techniques have evolved rapidly and become an
accepted alternative to open aortic aneurysm repair. Theyhave
also generated new complications including stent-graft (SG)
migration and endoleak formation and therefore altered the
way patients are followed after repair.1 Unlike the minimal
imaging required after open surgical repair, patients having
endovascular repair of thoracic aortic aneurysms (TEVAR)
require lifelong postoperative surveillance imaging.2
Although the detection and management of endoleaks
after abdominal endovascular aortic aneurysm repair have
been well described, few reports have been published about
endoleaks after TEVAR.3-6 This investigation was per-
formed to evaluate the incidence and the determinants of
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ventions in patients with endoleaks were also evaluated.
METHODS
Population and Management
Between January 2000 andMarch 2008, 61 patients had endovascular re-
pair for thoracic aortic aneurysm (TAA). Thoracoabdominal aneurysms and
acute type B dissectionswere not considered in this analysis. TAAs included
atherosclerotic or dissecting aneurysms (n ¼ 52, ruptured n ¼ 4) and trau-
matic aneurysms (n ¼ 9, chronic n ¼ 2). The study cohort contained 54
men, with a mean age of 63.6 17.9 years (range: 17–87 years). All elective
patients had preoperative evaluationwith echocardiography and spirometry;
computed-tomography angiography (CT-A) of the brain was performed
when the lesion involved the aortic arch or the distal portion of the arch in
order to assess the integrity of the circle of Willis and the dominance of
the vertebral arteries. Three different devices were used: Talent (Medtronic
Vascular, Santa Rosa, Calif), Excluder (W. L. Gore and Associates, Flag-
staff, Ariz), and TX-1/TX-2 (Cook, Bloomington, Ind). The type of SG
has been chosen according to the aneurysm anatomic characteristics and
type of lesion. Generally, self-expanding SGs without bare stents were
used for traumatic aneurysms and proximal or distal extremity bare stents
in the proximity of the epiaortic branches or abdominal visceral vessels.
The study protocol was in compliance with the local Institutional Review
Board and received full approval.All patients gave their consent to participate.
Follow-up and Imaging Characteristics
After intervention, the follow-up imaging protocol included chest radio-
graphs and triple-phase CT-A performed at 1, 4, and 12 months after SGgery c October 2009
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CI ¼ confidence interval
CT ¼ computed tomography
CT-A ¼ computed-tomography angiography
LSA ¼ left subclavian artery
OR ¼ odds ratio
SG ¼ stent graft
TAA ¼ thoracic aortic aneurysm
TEVAR ¼ endovascular repair of thoracic aortic
aneurysm
implantation and annually thereafter. CT-A was performed using a 64-de-
tector row (Aquilion, Toshiba, Zoetermeer, Netherlands); initially, nonen-
hanced computed tomography (CT) images were obtained, then 80 to 90
mL (350/400 mg of iodine/mL) of a nonionic intravenous contrast material
(Iomeron, Bracco, Milano, Italy) were administered at a rate of 4 mL/s and
followed by a bolus of 40 mL of saline solution by using a power injector
(Envision CT Injector, Medrad, Pittsburgh, Pa). Arterial and venous phase
acquisitions were then performed. Arterial phase imaging was performed by
using bolus tracking. Arterial phase CT data acquisition was initiated when
the attenuation of a region of interest positioned in the ascending aorta
reachedþ150 Hounsfield units. Venous phase acquisition was initiated 90
seconds after the arterial phase. The nonenhanced CT arterial and venous
phase acquisitions were initiated at the level of the upper portion of the
neck and continued to the level of the celiac trunk. For nonenhanced CT ar-
terial and venous phase acquisitions, a 0.50-mm detector configuration was
used. Each phase data acquisition was performed in less than 10 seconds.
The postprocessing (multiplanar reconstructions, maximum intensity pro-
jection, 3-D images, and virtual angioscopy) was performed on a worksta-
tion (Vitrea, Vital Images, Plymouth, Minn). The patients were evaluated
for the presence of an endoleak, type of sac reperfusion, aneurysm expan-
sion, and endoleak intervention. Endoleaks were defined by a specific
team of radiologists blinded to the performed procedures. The CT-A exam-
inations were subsequently reevaluated on workstations by a team of a vas-
cular surgeon and an interventional radiologist, using multiplanar
reformatting capabilities and MIP/MPR/3-D reconstruction to identify and
classify the type of endoleak.
Definition
The intervention was classified as emergency when surgery was per-
formed within the first 24 hours after admission.7 The elective procedures
performed on the same admission day were not considered emergent.
Primary technical success was defined as successful deployment of the
SG without any type of endoleak at the end of the intervention, and second-
ary technical success was defined as the persistent exclusion of the aortic
disease after the second intervention (either endovascular or hybrid repair)
without occurrence of any other type of endoleak. A hybrid repair, as well as
‘‘debranching,’’ was intended as a combination of surgical and endovascu-
lar procedure. Location of the aortic disease was defined according to the
classification proposed by Criado and colleagues8 in terms of landing zones.
Type 1 endoleaks were classified on the basis of the location in contiguity
with the proximal (type A) or distal (type B) attachment site. Endoleaks
were classified as type 2 endoleak if the endoleak sac could not be seen com-
municating with the distal or proximal attachment site or if there was de-
layed enhancement of the endoleak sac. Type 3 endoleak was defined by
the junctional separation of two SGs. Grading of the aortic arch atheroma
was defined according to a previously reported modified classification9:
grade I (normal), smooth and continuous aortic intimal surface; grade II,
intimal thickening 3 to 5 mm; grade III, atheroma protruding< 5 mmThe Journal of Thoracic and Cinto aortic lumen; grade IV, atheroma protruding>5 mm into aortic lumen,
and ulcerated or pedunculated. During the follow-up, period shrinking was
defined a size reduction of 5 mm between 2 consecutive radiologic controls.
For all patients, the mean changes in maximal aortic diameter were calcu-
lated by comparing the baseline aortic diameter with the maximal diameter
at last follow-up, irrespective of endoleak treatment.
Data Analysis
Clinical data were prospectively recorded and tabulated with Microsoft
Excel (Microsoft Corp, Redmond,Wash). Continuous variables were tested
for normal distribution by the Kolmogorov-Smirnov test and compared be-
tween groups with unpaired Student t test for normally distributed values;
otherwise, the Mann-WhitneyU test was employed. In case of dichotomous
variables, group differences were examined by chi-square or Fisher exact
tests as appropriate.
A stepwise logistic regression model was developed to identify patient
and procedural variables associated with endoleak development. The model
was built using variables that demonstrated a P value< .20 in univariable
analysis. The strength of the association of variables with the endoleak
was estimated by calculating the odds ratio (OR) and 95% confidence inter-
val (CI). The discrimination of the model was obtained by calculating the
area under the receiver operating characteristic curve; the calibration of
the model, by the Hosmer-Lemeshow goodness-of-fit test. Survival rate
and freedom from reinterventions were estimated by means of the
Kaplan-Meier method.
Results are expressed as mean standard deviation for continuous vari-
ables and frequencies for the categorical ones. Statistical analysis was com-
puted with SPSS, release 13.0 for Windows (SPSS Inc, Chicago, Ill).
RESULTS
Clinical Univariable Data
Among the 61 TEVAR cases, emergency procedures were
performed in 20 patients (31.7%). Endoleaks were detected
in 9 (14.5%) subjects, of which 7 (77.8%) were type 1
(4 type A, 3 type B). None of the patients had more than 1
endoleak type. Endovascular or hybrid intervention was
used to treat the endoleaks in all but 1 patient; 1 type 1A en-
doleak spontaneously thrombosed. Five endoleaks (type 1A,
n ¼ 4 and type 2, n ¼ 1) were diagnosed during the initial
postoperative CT-A at 30 days. Four endoleaks developed
late; mean delay of endoleak appearance was 12months (me-
dian: 9, range: 6–24 months). Patients with endoleak and pa-
tients without it were comparable in terms of clinical
characteristics (Table 1). Briefly, age distribution was similar
(72.2  5.1 vs 62.1 19.0 years, P ¼ .176) as well as mean
standard EuroSCORE (European System for Cardiac Opera-
tive Risk Evaluation) (8.4 2.2 vs 8.8 3.7, P¼ .751). No
statistical differences were noted in terms of distribution of
the aortic diseases. Four patients (44.4%) in the endoleak
group and 10 (18.8%) among those without endoleak have
had previous thoracic or abdominal aortic surgery.
Morphological Univariable Data
No differences were detected regarding the extension and
morphology (saccular or fusiform) of the aneurysm (P ¼
.077 and P ¼ .478, respectively). No differences were also
observed regarding the surgical access and the SG used
(P ¼ .796 and P ¼ .724, respectively). In contrast, theardiovascular Surgery c Volume 138, Number 4 881
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nificantly different (P¼ .003; Table 2). SG diameter, length
of covered aorta, and number of SGs were also significant (P
¼ .003, P¼ .022, P¼ .002, respectively). Lesions involving
the proximal descending aorta were associated with lower
endoleak occurrence (11.1% vs 51.9%, P< .001). The
left subclavian artery (LSA) was covered by SG in 24 cases
(88.9% vs 31.4%, P ¼ .002).
Outcome of Univariable Data
Hospital mortality was 8.2%; no difference was noted
(11.1% vs 7.7%, P ¼ .563). The cause of death of the
only patient who died in the endoleak group was rupture
of an undetected type 1A endoleak that occurred 6 days after
the intervention. The patient died while entering the operat-
ing room for an endovascular attempt to seal the rupture.
Conversely, in the control group, 2 patients died because
of a myocardial infarction and 2 of respiratory failure. Post-
operative complications were registered in 12 patients. Cere-
brovascular accidents were observed in 6 (9.8%) subjects.
In detail, 3 patients had transient ischemic attack without se-
quelae, and the other 3 subjects had major cerebrovascular
events (stroke). Paraplegia was not encountered in our pop-
ulation. Concerning renal failure, 4 patients (4.2%) had
a transient increase in creatinine level (>200 mmol/L),
whereas 2 subjects required temporary dialysis therapy for
a median of 48 hours.
No open conversions were performed; primary technical
success rate was 95% (58 of 61 cases). In the endoleak group,
5 patients required additional vascular or endovascular proce-
dures to complete or in association with TEVAR (55.6% vs
36.5%, P ¼ .298). Secondary technical success rate was
100%; intervention included additional SG (n ¼ 4) and total
debranching (n ¼ 2) to treat type 1 endoleaks, whereas both
type 2 endoleaks were sealed with embolization of the origin
TABLE 1. Clinical characteristics of the enrolled patients
Variable*
Endoleak
(n ¼ 9)
No endoleak
(n ¼ 52) P value
Age
Mean 72.2  501 62.1  19.0 .176
Range 64–80 17–87
Male sex, n (%) 8 (88.9) 46 (88.5) .999
Hypertension, n (%) 9 (100) 40 (76.9) .184
Diabetes, n (%) 0 (0) 4 (7.7) .999
Dyslipidemia, n (%) 2 (22.2) 10 (19.1) .999
COPD, n (%) 5 (55.6) 21 (40.4) .477
Renal failure, n (%) 2 (22.2) 11 (21.1) .999
Coronary artery disease, n (%) 1 (11.1) 15 (28.8) .423
Cerebrovascular accident, n (%) 1 (11.1) 7 (13.5) .999
History of aneurysm, n (%) 2 (22.2) 23 (44.2) .286
EuroSCORE 8.4  2.2 8.8.  3.7 .751
COPD, Chronic obstructive pulmonary disease; EruoSCORE, European System for
Cardiac Operative Risk Evaluation. *For continuous variables: mean and standard
deviation; for categorical variables: n (%).882 The Journal of Thoracic and Cardiovascular Surof the LSA. Clinical and imaging follow-up was 100%
complete as no surviving patient was lost to follow-up.
Mean follow-up was 32.4 months (median: 26, range: 1–96
months). The percentage of patients free from reintervention
was 94.6%  3.0%, 88.3%  4.5%, and 85.4%  5.2%,
at 1, 2 and 5 years, respectively (Figure 1, A). The actuarial
survival estimates at 1, 2, and 5 years after the procedure
were 85.2%  4.6%, 78.1%  5.4%, and 70.6% 
6.4%, respectively (Figure 1, B). Follow-up mortality oc-
curred in 12 patients, including 3 with respiratory failure, 6
with myocardial infarction, 2 with lung cancer, and 1 with
massive pulmonary embolism.
Two patients developed further endoleaks during the fol-
low-up period: 1 patient treated for a type 1B endoleak devel-
oped a type 2 from the intercostal-thyroid trunk that was
embolized, and 1 patient treated for a type 2 endoleak devel-
oped a type 1A endoleak that required total debranching.
Multivariable Analysis
Multivariate analysis demonstrated that the diameter of
aneurysmal aorta (OR 1.75, 95% CI 1.07–2.86) and the
TABLE 2. Aneurysm and procedure details
Variable*
Endoleak
(n ¼ 9)
No endoleak
(n ¼ 52) P value
TAA characteristics
Diameter (mm) 7.7  2.2 5.4  1.6 .033
Length (mm) 16.0  8.1 11.7  7.8 .077
TAA morphology .478
Saccular, n (%) 3 (33.3) 26 (50.0)
Fusiform, n (%) 6 (66.7) 26 (50.0)
Aortic atheroma degree .843
Grade I 4 (44.4) 29 (55.8)
Grade II 4 (44.4) 16 (30.8)
Grade III 1 (11.1) 6 (11.5)
Grade IV 0 (0) 1 (1.9)
SG characteristics
Stent diameter (mm) 39.0  2.5 34.8  4.3 .003
Coverage length (mm) 20.7  5.8 18.3  20.3 .022
No. stents 1.9  0.9 1.2  0.5 .002
SG landing zone <.001
LCA, n (%) 3 (33.6) 2 (3.8)
LSA, n (%) 5 (55.6) 7 (13.5)
Prox DTA, n (%) 1 (11.1) 27 (51.9)
Dist DTA, n (%) 0 (0) 16 (30.8)
SG used .724
Excluder, n (%) 4 (44.4) 27 (51.9)
Talent, n (%) 3 (33.3) 11 (21.2)
TX-1/TX-2, n (%) 2 (22.2) 4 (26.9)
LSA coverage 8 (88.9) 16 (31.4) .002
Surgical access .796
Femoral artery 8 (88.9) 46 (88.5)
Iliac artery 1 (11.1) 4 (7.7)
Aorta 0 (0) 2 (3.8)
LCA, left carotid artery; LSA, left subclavian artery; DTA, descending thoracic aorta;
SG, stent graft; TAA, thoracic aortic aneurysm; Prox, prosimal; DIST, distal. *For con-
tinuous variables: mean and standard deviation; for categorical variables: n (%).gery c October 2009
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FIGURE 1. Actuarial freedom form reintervention (A) and actuarial survival (B).A
C
Dcoverage of the LSA (OR 12.05, 95 CI% 1.28–113.30)
were independently associated with endoleak develop-
ment. With all patients considered, the variables of the
model correctly predicted 87% of the observed cases of
postoperative endoleak. The area under the receiver oper-
ating characteristic curve for this model was .896, sug-
gesting a good ability to distinguish between individuals
who will develop endoleak and those who will not. The
Hosmer-Lemeshow goodness-of-fit test was not significant
for lack of fit (c2 [7 df] ¼ 2.79, P ¼ .904), indicating
that there was no statistically significant departure from
a perfect fit. Figure 2 displays the probability of patient
endoleak occurrence in relation to the number of SG,
native aortic diameter, and LSA coverage.
DISCUSSION
In contrast to the available data on endoleaks after abdom-
inal aortic repair, little has been published regarding the in-
cidence and predictive factors of endoleak after TEVAR.4,10
Earlier series reported an endoleak rate in the range of 5% to
30%, including data from single-center series and multicen-
ter registries.4-6,10,11 In the interesting analysis of Parmer
and colleagues,4 the authors published a 29% endoleak
rate in a series of 105 patients treated for TAAs only. Our
experience is somewhat different; in fact, we observed
a lower endoleak occurrence (14.7%) without differences
in terms of comorbidities or disease characteristics between
patients with and without endoleaks. In our patient popula-
tion, a larger aortic diameter at the time of repair was predic-
tive of endoleaks, but in contrast to the data of Parmer and
associates,4 the disease extension was not statistically pre-
dictive of postoperative endoleak occurrence. Moreover,
a higher number of devices and a larger size did not provide
superior results in terms of endoleak prevention.
In most of the published studies, endoleaks were related to
the proximal or distal landing zones (12,13). Verhoye and
colleagues,10 in a retrospective analysis of 54 TEVAR
procedures, observed a relevant endoleak rate of 40% (9/
22 cases, 1 ruptured) for degenerative TAAs and concluded
that longer SG and a longer (>3 cm) neck reduced the likeli-
hood of proximal endoleaks. In our series, a lengthier aorticThe Journal of Thoracic and Ccoverage was not protective against endoleaks, suggesting
that a more liberal stenting of normal aorta is not justified.
Conversely, the proximal landing zone strongly predicted
a TEVAR failure, especially when SG attachment involved
the proximity of the LSA, which resulted in an independent
risk for postoperative endoleaks. Our findings are supported
by the outstanding study of Demers and colleagues12: in
their series, the transposition of the LSA was an independent
risk factor for treatment failure, probably reflecting a subop-
timal proximal landing zone because of pathological anat-
omy. Moreover, abrupt angulation, vector forces acting on
the SG, and cantilevering the proximal SG end off the lesser
curve of the distal arch have also been implicated in endo-
leak formation.12 Therefore, the proximal landing zone in
the rectilinear portion of the descending aorta should be
strongly regarded as the most favorable target to obtain an
effective and persistent sealing. Nevertheless, overstenting
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FIGURE 2. Predicted probability for developing endoleak by the diameter
of the aneurysmal aorta (mm) and the number of the inserted stent grafts
with reference to the position of the landing zone (red line, coverage of
left subclavian artery; black lines, no coverage of left subclavian artery).
As the diameter of the aneurysmal aorta and number of stent grafts increase
with coverage of the left subclavian artery, the probability of developing en-
doleak also increases (eg, for a patient with 60 mm of native aorta diameter
requiring 3 stent grafts and the coverage of left subclavian artery, the prob-
ability of developing an endoleak is about 65%).ardiovascular Surgery c Volume 138, Number 4 883
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total epiaortic debranching should be more frequently per-
formed to avoid an increased risk of endoleaks formation.
Tailoring an appropriate landing zone remains mandatory
to obtain efficacious immediate and durable results.
The longer duration of follow-up reported herein allowed
the detection of several late complications. Demers and
associates12 showed actuarial freedom from primary or
secondary endoleak of 78% and 64% at 1 and 5 years,
respectively, and actuarial freedom from aortic reinterven-
tion was 83% and 77% at these same times. Similar free-
dom from reintervention was observed in our patients.
Concerning the rate of surgical conversion, our data are in
accordance with Grabenwoger and colleagues,6 who re-
ported a 5% rate of surgical conversion after TEVAR. A
higher percentage of reintervention after SG treatment for
atherosclerotic aneurysms was also noted in our patients.
We demonstrated that the chronic enlargement of the non-
covered aorta favored the development of type 1 endoleaks.
However, we did not confirm that a shorter landing zone is
a predictive factor for endoleaks.
Secondary type 1 endoleaks have been thought to be also
the result of SG migration following inadequate fixation.14
According to the literature, late migration occurred with an
incidence of 0% to 30%, typically higher for early genera-
tion devices.8,13,15 Like Demers and colleagues,12 we did not
observe SG migration during follow-up in patients with
secondary endoleaks. However, this complication should
be promptly suspected and then recognized with early reex-
amination.4,10,16 In our experience, this recommendation is
supported by the fact that the only patient who died of a pro-
cedure-related complication in the endoleak group had a fatal
rupture of the aneurysmal sac after an undetected endoleak.
Type 1 endoleak should be treated aggressively when found.
Similar to the approach suggested for endoleak after abdom-
inal endovascular repair, thoracic endoleaks have been sug-
gested to be preferentially approached with an endovascular
procedure.17,18 Our experience is consistent with the find-
ings of Verhoye and colleagues,10 who surgically converted
just 1 of the 16 endoleaks detected postoperatively. Satisfac-
tory repair of all endoleaks in our study was confirmed by the
100% secondary technical success leading to persistent
exclusion of the aortic disease.
This study is limited by its interpretations from a single
center only and further, by its retrospective analysis, al-
though data were prospectively collected. However, the
study design is shared with previous reports.3-6 The study
is also limited in statistical terms based on relatively few
observations. Another limitation of the study was the lack
of information concerning the aortic diameter at the landing
zones and the length of landing zones. However, these vari-
ables are hard to define, and the measurements of the tho-
racic aorta, especially in the arch curve, are very difficult
to standardize; in addition, the proximal sealing point is884 The Journal of Thoracic and Cardiovascular Surnot so exactly respected during the deployment procedure
as well as the length of landing zones.
In conclusion, in our study, the diameter of the aneu-
rysmal aorta and the position of the landing zone are
the most relevant factors in endoleak occurrence after TE-
VAR procedures. A careful follow-up program should be
mandatory, because most endoleaks may be treated suc-
cessfully by additional endovascular procedures. More-
over, overstenting the LSA with a subsequent LSA
revascularization when required or the entire epiaortic de-
branching should be more frequently performed to prevent
endoleak formation.
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Piffaretti et al Acquired Cardiovascular DiseaseAppendix. Variables Included in Multivariable Analysis
Clinical variables: age, hypertension, length of stay,
bleeding (12 hours).
Operative variables: thoracic aortic aneurysm length,
thoracic aortic aneurysm diameter, stent graft diameter, stent
graft coverage length, number of stent grafts, stent graft
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